secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK:        0001100682
Form:       8-K
Filed at:   2025-08-06T23:59:59+00:00
Accession:  0001100682-25-000032
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Charles River Q2 non-GAAP EPS $3.12 beats; raises 2025 guidance; DOJ closes NHP probe
--------------------------------------------------------------------------------

- Q2 revenue $1.032B (+0.6% reported; organic -0.5%); GAAP EPS $1.06, non-GAAP EPS $3.12 up 11.4% YoY.
- Non-GAAP operating margin improved to 22.1% from 21.3%; DSA non-GAAP margin slightly up to 27.4%.
- Raises FY2025 non-GAAP EPS guidance to $9.90-$10.30 (prior $9.30-$9.80); revenue growth (2.5%)-(0.5%).
- DOJ closes grand jury and civil investigations into NHP supply chain; no action taken.
- Segment organic growth: RMS +2.3%, DSA -2.4%, Manufacturing +2.9%; cost savings from restructuring.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1100682/000110068225000032/0001100682-25-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1100682/000110068225000032/crl-20250806.htm
  HTML page:      https://secwatch.observer/filing/0001100682-25-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer